158 related articles for article (PubMed ID: 17698659)
1. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins.
Delgrange D; Pillez A; Castelain S; Cocquerel L; Rouillé Y; Dubuisson J; Wakita T; Duverlie G; Wychowski C
J Gen Virol; 2007 Sep; 88(Pt 9):2495-2503. PubMed ID: 17698659
[TBL] [Abstract][Full Text] [Related]
2. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III.
Kim S; Welsch C; Yi M; Lemon SM
J Virol; 2011 Jul; 85(13):6645-56. PubMed ID: 21525356
[TBL] [Abstract][Full Text] [Related]
4. The stability of secreted, acid-labile H77/JFH-1 hepatitis C virus (HCV) particles is altered by patient isolate genotype 1a p7 sequences.
Atkins E; Tatineni R; Li H; Gretch D; Harris M; Griffin S
Virology; 2014 Jan; 448():117-24. PubMed ID: 24314642
[TBL] [Abstract][Full Text] [Related]
5. The Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion.
Etienne L; Blanchard E; Boyer A; Desvignes V; Gaillard J; Meunier JC; Roingeard P; Hourioux C
PLoS One; 2015; 10(9):e0137182. PubMed ID: 26339783
[TBL] [Abstract][Full Text] [Related]
6. Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.
Takeda M; Ikeda M; Ariumi Y; Wakita T; Kato N
J Gen Virol; 2012 Jul; 93(Pt 7):1422-1431. PubMed ID: 22456614
[TBL] [Abstract][Full Text] [Related]
7. Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.
Murayama A; Kato T; Akazawa D; Sugiyama N; Date T; Masaki T; Nakamoto S; Tanaka Y; Mizokami M; Yokosuka O; Nomoto A; Wakita T
J Virol; 2012 Feb; 86(4):2143-52. PubMed ID: 22156532
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells.
Shih CM; Lo SJ; Miyamura T; Chen SY; Lee YH
J Virol; 1993 Oct; 67(10):5823-32. PubMed ID: 8396658
[TBL] [Abstract][Full Text] [Related]
9. Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity.
Alsaleh K; Delavalle PY; Pillez A; Duverlie G; Descamps V; Rouillé Y; Dubuisson J; Wychowski C
J Virol; 2010 Dec; 84(24):12515-28. PubMed ID: 20943968
[TBL] [Abstract][Full Text] [Related]
10. NS2 is dispensable for efficient assembly of hepatitis C virus-like particles in a bipartite trans-encapsidation system.
Bentham MJ; Marraiki N; McCormick CJ; Rowlands DJ; Griffin S
J Gen Virol; 2014 Nov; 95(Pt 11):2427-2441. PubMed ID: 25024280
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of infectious hepatitis C virus chimera containing structural proteins directly from genotype 1b clinical isolates.
Lu J; Tao W; Li R; Xiang Y; Zhang N; Xiang X; Xie Q; Zhong J
Virology; 2013 Aug; 443(1):80-8. PubMed ID: 23706810
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy to develop a robust infectious hepatitis C virus cell culture system directly from a clinical isolate.
Lu J; Xiang Y; Tao W; Li Q; Wang N; Gao Y; Xiang X; Xie Q; Zhong J
J Virol; 2014 Feb; 88(3):1484-91. PubMed ID: 24227861
[TBL] [Abstract][Full Text] [Related]
13. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
[TBL] [Abstract][Full Text] [Related]
14. A laboratory-adapted HCV JFH-1 strain is sensitive to neutralization and can gradually escape under the selection pressure of neutralizing human plasma.
Song H; Ren F; Li J; Shi S; Yan L; Gao F; Li K; Zhuang H
Virus Res; 2012 Oct; 169(1):154-61. PubMed ID: 22846920
[TBL] [Abstract][Full Text] [Related]
15. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
Bungyoku Y; Shoji I; Makine T; Adachi T; Hayashida K; Nagano-Fujii M; Ide YH; Deng L; Hotta H
J Gen Virol; 2009 Jul; 90(Pt 7):1681-1691. PubMed ID: 19282429
[TBL] [Abstract][Full Text] [Related]
16. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.
Pokrovskii MV; Bush CO; Beran RK; Robinson MF; Cheng G; Tirunagari N; Fenaux M; Greenstein AE; Zhong W; Delaney WE; Paulson MS
J Virol; 2011 Apr; 85(8):3978-85. PubMed ID: 21289124
[TBL] [Abstract][Full Text] [Related]
18. Genotype 1a HCV (H77S) infection system.
Yi M; Lemon SM
Methods Mol Biol; 2009; 510():337-46. PubMed ID: 19009273
[TBL] [Abstract][Full Text] [Related]
19. Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.
Date T; Kato T; Kato J; Takahashi H; Morikawa K; Akazawa D; Murayama A; Tanaka-Kaneko K; Sata T; Tanaka Y; Mizokami M; Wakita T
J Virol; 2012 Oct; 86(19):10805-20. PubMed ID: 22787209
[TBL] [Abstract][Full Text] [Related]
20. The Arg719 residue at the C-terminal end of the stem region in hepatitis C virus JFH-1 E2 glycoprotein promotes viral infection.
Qin ZL; Ju HP; Wang WB; Ren H; Guan M; Zhao P; Qi ZT
Virus Res; 2013 Mar; 172(1-2):1-8. PubMed ID: 23201584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
